Synthetic Genomics Inc. Signs Collaborative Research and Development Agreement with Lung Biotechnology Inc., a Subsidiary of United Therapeutics Corporation, to Develop Humanized Pig Organs to Revolutionize Transplantation Field

[PR Newswire] – LA JOLLA, Calif. and SILVER SPRING, Md., May 6, 2014 /PRNewswire/ — Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic driven advancements in a variety of industries, and Lung Biotechnology Inc more

View todays social media effects on UTHR

View the latest stocks trending across Twitter. Click to view dashboard

See who United is hiring next, click here to view